Compensation & Benefits Strategy for Pharma Companies in Europe
You're competing with Big Pharma for talent. Your pay structure was built one country at a time.
A senior scientist in Copenhagen benchmarks your offer against the Big Pharma anchor across town. A field rep in Frankfurt knows exactly what the chemical industry agreement pays. A quality lead in Belgium expects the 13th-month salary and automatic indexation, because every employer she has ever had provided both. They all operate inside pay structures that took decades to build. Yours was assembled one hire at a time, and from June 2026 the EU Pay Transparency Directive puts it on display.
Europe HR Solutions builds compensation and benefits strategies for pharma and life sciences companies scaling across Europe: competitive in markets anchored by Big Pharma, consistent across your footprint, and compliant with the collective agreements, employment law, and pay transparency rules in every country you operate in.
Who We Are
European Comp & Benefits Expertise for Scaling Life Sciences Companies
Unlike global comp consultants who deliver a benchmarking report and leave you to figure out the local rules, we build the implementation: country-specific pay bands, collective agreement mapping, benefits structures, incentive design, and recruitment transparency policies, all built to work together across your European footprint.
Unlike payroll providers who process what you decide but never touch strategy, we design the compensation architecture that sits above the payroll. What should a senior regulatory affairs manager earn in Belgium vs. Denmark? Which collective agreement covers your German site, and what does it do to your pay bands? How do you run one incentive plan for a field force operating under five different legal regimes? We answer these questions market by market.
Clients
Countries
Years Of Experience
Consultants
The Real Cost of Getting Pharma Comp Wrong in Europe
When you grew from one European market to five, every hire was solved locally. A recruiter benchmarked the salary, the contract followed whatever the local lawyer had on file, and benefits matched whatever the first employee in that country negotiated. Now you have R&D in two countries, a field force in four, and a pay landscape where the same job title means a different salary, a different bonus, and a different pension depending on who hired first.
You're losing specialist talent to employers with anchored, transparent pay
In European life sciences hubs, pay expectations are set by Big Pharma and the candidates know it. Regulatory affairs, biostatistics, medical affairs, and QP roles are scarce enough that strong candidates hold multiple offers, and from June 2026 the EU Pay Transparency Directive requires salary ranges in job postings. If your posting says “competitive salary” while the anchor employer in that market publishes a graded scale, you are not in the consideration set. You are the offer candidates use as leverage.
Collective agreements set pay floors and raises you didn't budget for
In Germany, chemical and pharma industry agreements define pay grades and negotiated annual increases. In Belgium, automatic wage indexation raises your entire payroll whether you planned for it or not. In France, the pharmaceutical industry collective agreement assigns every role a classification level with a minimum salary attached. Misclassify a role, or ignore the grid entirely, and you build up back-pay liability with every payslip.
One framework, four very different workforces
Your biostatistician in Leiden benchmarks against biotech hubs and expects a premium for scarcity. Your quality engineer in Frankfurt sits in a collective agreement grade with a defined salary band. Your field rep in Lyon earns half her income through variable pay. Your regulatory lead compares offers across three countries at once. Stretch a single pay philosophy across all four and it breaks somewhere. Usually in the population you can least afford to lose.
Your field force incentives don't transfer across borders
The incentive plan that works in one market can be non-compliant or unenforceable in the next. Variable pay sits inside collective agreements and employment contracts, works councils in Germany have a say in how targets and bonus systems are set, and the rules on changing or withholding variable pay differ in every country. A global plan rolled out without local adaptation creates disputes exactly where your revenue depends on motivated people.
The EU Pay Transparency Directive is about to make all of this public
The Directive’s June 2026 obligations hit pharma harder than most. Salary ranges become mandatory in postings for roles where you’re already losing candidates. Pay gap reporting must reconcile graded collective agreement populations with ungraded scientific roles, and a field force whose variable pay counts toward the calculation. Gaps above 5% without objective justification trigger remediation. Every informal pay decision you’ve made country by country becomes something your own employees can legally question.
European Compensation Benchmarking & Pay Band Design
Market-by-market benchmarking for life sciences roles: R&D, clinical, regulatory, medical affairs, quality, manufacturing, and commercial, using real European life sciences hiring data, not generic cross-industry surveys. We design pay bands that are locally competitive, internally equitable, and structured to meet EUPTD transparency requirements from day one.
Collective Agreement & Statutory Pay Mapping
We identify which collective agreements apply to each site and population, map your roles to the correct classification levels, and build the negotiated increases and indexation mechanics into your comp budget. Your pay bands respect every local floor, and your European comp cost becomes forecastable instead of a recurring surprise.
Statutory & Market Benefits Design
We identify mandatory benefits in each country (pension, insurance, meal vouchers, transport), map market-standard benefits for life sciences talent (company cars for field roles, private health, learning budgets), and design a benefits framework that’s consistent across your European footprint while respecting local requirements and expectations.
Variable Pay, Incentive & Retention Design
Field force incentive plans that keep one global logic but comply in every country, with works council and collective agreement constraints designed in from the start. Plus retention structures for the scientific and regulatory staff your pipeline depends on, built to hold people through long development cycles.
EU Pay Transparency Directive Readiness
We embed EUPTD compliance into your comp strategy from the start: salary range definitions for job postings, gender-neutral job architecture, pay gap assessment, and reporting preparation. For pharma companies scaling across Europe, building transparency into the comp framework now is cheaper and faster than retrofitting it after the Directive takes effect.
Our Services / What We Coordinate
Compensation & Benefits Services for Pharma Companies in Europe
Trusted by Pharma Companies Scaling Their European Teams
Long-term partnerships built on trust, speed, and deep knowledge of European compensation and labor law.
We’ve been working with EHRS for a long time and it’s always the same pleasure to work together. Thank you for your confidence, your enthusiasm and your professionalism!
Lionel Paraire
Associate Director
Working with EHRS has helped the wider HR team in managing workloads, and our partners are starting to see the benefit of this relationship.
Paula Stillman
Head of HR
These experts are incredibly knowledgeable and professional. I can contact them and feel confident in knowing that I will receive accurate guidance.
Jess Clark
Employee Relations Specialist
Why Work With Europe HR Solutions
Comp & Benefits Expertise Built for How Pharma Companies Actually Scale
Your comp challenges aren’t the same as a tech company’s or a manufacturer’s. You’re hiring scarce scientific talent in markets anchored by Big Pharma, running a field force under five legal regimes, and managing collective agreement pay grids next to ungraded R&D roles. We build comp strategies for that reality.
Life-Sciences-Specific Compensation Knowledge
We understand how pharma companies pay: graded structures for regulated populations, premium bands for scarce scientific skills, incentive-heavy field force packages, and the constant pressure to stay competitive against Big Pharma anchors without Big Pharma budgets. We build comp frameworks for pharma, biotech, and life sciences companies scaling across Europe.
Local Expertise in 30+ European Markets
Every country has its own collective agreements, mandatory benefits, indexation rules, and market norms for life sciences talent. We don’t generalize. We build country-specific comp packages informed by real-time local market data and regulatory knowledge.
Comp Strategy in Weeks, Not Quarters
Market benchmarking and pay band design in 3–4 weeks. Collective agreement and statutory pay mapping per country in 2–3 weeks. Full multi-country comp framework in 6–8 weeks. We move at the pace scaling pharma companies hire, not the pace of a Big 4 compensation study.
One Partner From Strategy Through Implementation
We don’t hand you a benchmarking report and wish you luck. We build the pay bands, map the collective agreements, design the benefits packages, structure the incentives, and prepare you for EUPTD reporting. Same team, no handoff.
Frequently Asked Questions for Pharma Companies
We're a 400-person pharma company with teams in six European countries. Do we really need a formal comp framework?
Yes, and you probably needed it 50 hires ago. Across six countries you already have collective agreement obligations in some markets, ad hoc pay decisions in all of them, and inconsistencies you haven’t measured. The EU Pay Transparency Directive will make those inconsistencies visible to your own employees. A formal framework now prevents a painful remediation later and immediately improves your ability to make competitive offers and retain specialist staff.
Can you work within collective agreements and still keep one global structure?
Yes. Collective agreements set floors and classification grids, not ceilings. We design a global comp architecture first, then map it to each local grid so every role sits at or above the correct classification level. There’s a cost-control benefit too: once indexation and negotiated increases are mapped, your European comp cost becomes forecastable instead of a recurring budget surprise, which is usually the first thing the CFO thanks us for.
How do we compete for scientific talent in markets dominated by Big Pharma?
Not by out-paying them across the board, which you can’t, but by positioning deliberately against them. That means knowing exactly where the anchor employers sit in each market, deciding which roles you pay at or above that level and which you don’t, and competing on the parts of the package where a scaling company wins: broader scope, faster decisions, visible impact, and pay transparency the candidate can verify. A deliberate position beats an accidental one in every negotiation.
How should we structure incentives for our field force across countries?
Keep one global plan logic (what you measure, how targets are set, how payout curves work) and build a compliant local wrapper in each country. That means checking the plan against collective agreements, involving works councils where required, getting the contractual language right so you can adjust targets without renegotiating contracts, and documenting target-setting so disputes don’t turn into liabilities.
How does the EU Pay Transparency Directive affect pharma companies specifically?
The hard part for pharma is the reconciliation work. Collective agreement populations already have documented grades, while scientific and commercial roles usually don’t, and the Directive expects one defensible job architecture across both. Variable pay complicates the picture further for field-heavy organizations. The companies that handle this well start with a quiet internal pay gap assessment now, fix what they find on their own timeline, and walk into the reporting obligations with nothing to explain.
What does a typical engagement look like?
We start with a diagnostic of your current pay landscape across countries, then move through benchmarking and pay band design, collective agreement mapping, benefits and incentive design, and EUPTD readiness. Most multi-country frameworks are complete in 6–8 weeks. You can also engage us for a single piece, such as field force incentives or pay bands for one new market.
Build a comp structure that wins specialist talent. Start with a conversation.
Not sure where to start? Talk to a HR expert.
Whether you’re losing candidates to better-anchored offers, untangling collective agreement obligations, preparing for the EU Pay Transparency Directive, or simply want a comp framework that scales, a short conversation can bring immediate clarity.
Our role is to understand your specific European footprint, your hiring goals, and your current compensation approach, and outline the most effective path to a structure that attracts talent and stays compliant.
No obligation, no pressure. Just clear, practical guidance from senior HR professionals who build compensation strategies for life sciences companies across Europe.